Answers are grounded in this paper and cite their sources.
C(sp3)-rich bicyclic hydrocarbon scaffolds, as exemplified by bicyclo[1.1.1]pentanes (BCPs), play an increasingly high-profile role as saturated bioisosteres of benzenoids in medicinal chemistry and crop science. Substituted bicyclo[2.1.1]hexanes (BCHs) are new emerging bicyclic hydrocarbon bioisosteres for ortho- and meta-substituted benzenes, which to date remain difficult to access. Therefore, a general synthetic route to BCHs is urgently needed, if their potential as bioisosteres is to be realized. Here, we describe a broadly applicable catalytic approach that delivers substituted BCHs by a highly atom-economical intermolecular coupling between olefins and bicyclo[1.1.0]butyl (BCB) ketones. The SmI2–catalyzed process embraces a wide range of electron-deficient alkenes and substituted BCB ketones, operates with loadings of SmI2 as low as 5 mol%, and is underpinned by a radical-relay mechanism that is supported by DFT calculations. The product BCH ketones have been shown to be versatile synthetic intermediates through selective downstream manipulation, and the expedient synthesis of a saturated hydrocarbon analogue of the broad spectrum antimicrobial, phthalylsulfathiazole. Our findings have provided the first general catalytic approach to the substituted BCH scaffold, and serve as a launchpad for the widespread use of this largely unexplored family of bioisosteres in medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Agasti et al. (2022) studied this question.